Brian Mann
-
A diplomatic row has frozen U.S.-Mexican efforts to target drug cartels. American officials say illicit fentanyl from labs in Mexico is driving a surge in overdose deaths. -
Under a bankruptcy procedure prohibited by courts in part of the country, the Sacklers could be sheltered from opioid lawsuits even without declaring bankruptcy. Some states are crying foul. -
With the deadly opioid fentanyl pushing overdose deaths to record levels, federal officials hope buprenorphine will save lives in parts of the country where the drug is rarely prescribed. -
Researchers say cocaine, meth and other street drugs are increasingly contaminated with deadly synthetic opioids, contributing to a major spike in deaths. -
The Biden administration points to fentanyl as the major culprit for the increase in deaths. Officials unveiled a new one-year strategy to reduce the number of fatalities from drug overdoses. -
More states including New York and Virginia are on the brink of legalizing marijuana. What does that mean for people of color who faced high rates of arrest for marijuana possession?
-
Companies that sold or distributed opioid medications face huge legal, financial and public relations peril. Critics say shareholders, not CEOs, will pay the price. -
Companies that sold or distributed opioid medications face huge legal, financial and public relations peril. Critics say shareholders, not CEOs, will pay the price.
-
Two dozen states had hoped to sue the owners of Purdue Pharma for their alleged role in the opioid crisis. But a federal bankruptcy has judge put the brakes on — again — until April 21. -
Attorneys, forensic analysts and other financial experts working for Purdue Pharma spent nearly two years looking for evidence of wrongdoing by the Sacklers. Critics want the findings made public.
